FDA: Animal Testing No Longer Mandatory before Human Trials
Swathi Kodaikal, MSc
New FDA law is a “radical shift” in the field of pharmaceutical research and drug development
Drug Development
Ethics Not Only Allow but Demand Placebo in Some HIV Cure Trials
Rutgers University
Ethicists argue for the ethics of stopping antiretroviral treatment for patients who receive a placebo
US Clinical Trial Evaluating Antiviral for Monkeypox Begins
National Institutes of Health
NIH begins a Phase 3 clinical trial to gather data on tecovirimat
5 Trends in Biomedicine and Precision Wellness for the Next Decade
Katherine Tran, Maryam Goudarzi, PhD
Expect to see more streamlined integration of the state-of-the-art technologies
Advancing Your Career in Clinical Industry
Miriam Bergeret, MSc
Nevena Vicic, MSc, MBiotech, discusses how to take control of your career
Proof Positive: Decentralized Trials Drive Value
Ingrid Oakley-Girvan, PhD, MPH
Driving down costs and clarifying the value of trial components is imperative to get drugs to market
FDA Urges Companies to Be “Recall Ready” to Protect Public Health
U.S. Food and Drug Administration
New guidance to help companies prepare to quickly and effectively remove violative products from the market
Computer Simulations Are the New Frontier in COVID-19 Drug Trials
University of Waterloo
Models allow for virtual trials of drugs and vaccines, to test their efficacy against COVID-19
First Molecular Blueprint of Neuropeptide Receptor
Universität Leipzig
The blueprint will enable the development of tailor-made drugs to treat epilepsy or cardiovascular diseases
More Than 200 Genetic Factors Cause Heart Arrhythmias
Queen Mary University of London
Research results could one day lead to advanced screening methods to discern who is at greatest risk of developing disease